Inventor · disambiguated record
Laurence Fayadat-Dilman
Also filed as: FAYADAT-DILMAN LAURENCE
16 granted patents·15 pending applications·74 citations·filing 2015–2024
91Inventor score
Files withMERCK SHARP & DOHME17MERCK SHARP & DOHME LLC11BAILLY MARC ANDRE1FAYADAT DILMAN LAURENCE1WILLIAMS SYBIL M G1
Top patents by PatentIndex Score
31 records- 0198US10188730B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·42 cites·41 claims
- 0294US10618958B2Anti-TIGIT antibodiesMERCK SHARP & DOHME·Filed 2017·Granted Apr 14, 2020·10 cites·32 claims
- 0390US11278620B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Mar 22, 2022·3 cites·8 claims
- 0490US10766957B2Anti-TIGIT antibodiesMERCK SHARP & DOHME·Filed 2016·Granted Sep 8, 2020·7 cites·22 claims
- 0588US10898571B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Jan 26, 2021·2 cites·21 claims
- 0687US11072658B2Anti-PD-1/LAG3 bispecific antibodiesMERCK SHARP & DOHME·Filed 2019·Granted Jul 27, 2021·5 cites·19 claims
- 0786US2025064924A1Anti-tigit antibodiesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 0884US12102680B2Anti-TIGIT antibodiesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 1, 2024·1 cites·30 claims
- 0981US12102681B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME LLC·Filed 2022·Granted Oct 1, 2024·0 cites·12 claims
- 1079US10556957B2Anti-CD27 antibodiesMERCK SHARP & DOHME·Filed 2017·Granted Feb 11, 2020·4 cites·59 claims
- 1173US2024092902A1Methods for treating cancer or infection using a combination of an anti-pd-1 antibody, an anti-lag3 antibody, and an anti-tigit antibodyMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1271US12441792B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME·Filed 2021·Granted Oct 14, 2025·0 cites·13 claims
- 1371US12435133B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 7, 2025·0 cites·15 claims
- 1471US11207406B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·59 claims
- 1569US11111297B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·21 claims
- 1664US2021371530A1Anti-pd-1/lag3 bispecific antibodiesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1764US2024124607A1Proteins binding nkg2d, cd16, and ceacam5MERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1864US2021363256A1Anti-pd-1/lag3 bispecific antibodiesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1960US11958902B2Anti-TIGIT antibodiesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 16, 2024·0 cites·1 claims
- 2057US2017198042A1Anti-tigit antibodiesMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2157US2024358847A1Trop2 binders and conjugates thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2257US2017290914A1Anti-lag3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2356US2021363243A1Methods for treating cancer or infection using a combination of an anti-pd-1 antibody, an anti-lag3 antibody, and an anti-tigit antibodyMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2455US11045547B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2016·Granted Jun 29, 2021·0 cites·18 claims
- 2555US2020131272A1Anti-cd27 antibodiesMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2652US2016355589A1Anti-tigit antibodiesWILLIAMS SYBIL M G·Filed 2015·Application pending·0 cites
- 2752US2024002535A1Arginase 1 binders for inhibiting arginase 1 activityMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2852US2022251194A1Anti-pd-1/lag3/tigit trispecific antibodies and anti-pd-1/lag3 bicpecific antibodiesFAYADAT DILMAN LAURENCE·Filed 2020·Application pending·0 cites
- 2952US2024002533A1Arginase 1 binders for inhibiting arginase 1 activityMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3049US2024002534A1Arginase 1 binders for inhibiting arginase 1 activityBAILLY MARC ANDRE·Filed 2021·Application pending·0 cites
- 3146US12122834B2Anti-PD-1 antibodiesMERCK SHARP & DOHME LLC·Filed 2019·Granted Oct 22, 2024·0 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →